The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPageGroup Regulatory News (PAGE)

Share Price Information for PageGroup (PAGE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 442.00
Bid: 441.00
Ask: 441.60
Change: -4.80 (-1.07%)
Spread: 0.60 (0.136%)
Open: 456.40
High: 456.40
Low: 439.00
Prev. Close: 446.80
PAGE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Changes

23 Dec 2022 07:00

RNS Number : 6753K
PageGroup plc
23 December 2022
 

23 December 2022

PageGroup plc - Board changes

 

PageGroup plc, the specialist recruitment consultancy (the "Company") is pleased to announce the appointment of Babak Fouladi who will join the Board as an independent Non-Executive Director with effect from 10 April 2023.

The Company also announces that Patrick De Smedt, Senior Independent Director, does not intend to seek re-election to the Board at the Company's Annual General Meeting to be held in 2023, having served on the Board for seven years. The Company will announce in due course who will take over the role as Senior Independent Director when Patrick De Smedt steps down from the Board.

Babak Fouladi will be a member of the Audit, Nomination and Remuneration Committees.

Babak is currently Chief Technology & Digital Officer and Member of the Board of Management at Koninklijke KPN NV. Prior to this he has held a number of senior technology positions in the telecoms sector including Chief Technology Officer at MTN Group plc and Chief Technology Officer (Romania and then Spain) at Vodafone Group plc.

Angela Seymour-Jackson, Chair, commented:

"I am delighted to announce that Babak will be joining the Board. His extensive technology experience will complement the skills and experience of the Board.

I would also like to thank Patrick De Smedt for his invaluable contribution and counsel to the Board over the years."

There is no other information to be disclosed pursuant to LR9.6.13R in respect Babak Fouladi.

ENDS

 

Enquiries:

 

PageGroup

+44 (0)20 3077 8069

Kaye Maguire General Counsel & Company Secretary

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABLBDDGGDDGDD
Date   Source Headline
8th Jan 202110:12 amRNSNotice of Q4 and FY 2020 Trading Update
24th Dec 202010:54 amRNSBoard changes
18th Dec 202010:52 amRNSDirector Declaration
8th Dec 20201:06 pmRNSResults of External Audit Tender
7th Dec 20205:35 pmRNSDirector Declaration
14th Oct 20207:00 amRNSThird Quarter Update and COVID-19 Strategy
9th Oct 20201:32 pmRNSNotice of Third Quarter 2020 Trading Update
1st Oct 202010:14 amRNSBlock listing Interim Review
22nd Sep 20209:07 amRNSDirector Declaration
2nd Sep 20209:03 amRNSHolding(s) in Company
17th Aug 20209:45 amRNSHolding(s) in Company
5th Aug 20207:00 amRNSHalf Year Results
9th Jul 20207:00 amRNSSECOND QUARTER, FIRST HALF AND COVID-19 UPDATE
8th Jul 20209:04 amRNSNotice of Second Quarter 2020 Trading Update
4th Jun 20203:36 pmRNSResult of AGM
12th May 202011:03 amRNSNotice of 2020 Q2 Results
7th May 202011:12 amRNSHolding(s) in Company
1st May 202010:30 amRNSChange in Director’s Details
27th Apr 202012:31 pmRNSAnnual Report and Annual General Meeting
8th Apr 20207:00 amRNSFIRST QUARTER AND COVID-19 UPDATE
1st Apr 20203:00 pmRNSTotal Voting Rights
1st Apr 20201:30 pmRNSBlock listing Interim Review
20th Mar 20204:43 pmRNSSecond Price Monitoring Extn
20th Mar 20204:37 pmRNSPrice Monitoring Extension
20th Mar 202011:40 amRNSHolding(s) in Company
18th Mar 20202:24 pmRNSDirector/PDMR Shareholding
16th Mar 20201:12 pmRNSDirector/PDMR Shareholding
16th Mar 20201:09 pmRNSDirector/PDMR Shareholding
10th Mar 202011:59 amRNSHolding(s) in Company
5th Mar 20207:00 amRNSFinal Results
2nd Mar 20201:14 pmRNSTotal Voting Rights
28th Feb 202011:47 amRNSNotice of 2019 Full Year Results
14th Jan 20207:00 amRNSFOURTH QUARTER AND FULL YEAR 2019 TRADING UPDATE
9th Jan 20209:46 amRNSNotice of Q4 and Full Year 2019 Trading Update
2nd Jan 20209:00 amRNSTotal Voting Rights
20th Dec 20198:44 amRNSDirector Declaration
2nd Dec 20191:36 pmRNSTotal Voting Rights
22nd Nov 20191:30 pmRNSDirector/PDMR Shareholding
22nd Nov 20191:04 pmRNSDirector/PDMR Shareholding
8th Oct 20197:00 amRNSTHIRD QUARTER 2019 TRADING UPDATE
2nd Oct 201911:06 amRNSBlock listing Interim Review
2nd Oct 201910:03 amRNSTotal Voting Rights
21st Aug 201910:01 amRNSHolding(s) in Company
16th Aug 20199:59 amRNSHolding(s) in Company
7th Aug 20197:00 amRNSHalf-year Report
1st Aug 20199:19 amRNSNotice of 2019 Half Year Results
17th Jul 20193:26 pmRNSHolding(s) in Company
10th Jul 20197:00 amRNSSecond Quarter and First Half 2019 Trading Update
8th Jul 201912:26 pmRNSNotice of Q2 2019 Trading Update
3rd Jul 20193:22 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.